INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 170 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $236,000 | -10.6% | 5,700 | +81.0% | 0.02% | -15.4% |
| Q2 2018 | $264,000 | -30.7% | 3,150 | 0.0% | 0.03% | -48.0% |
| Q2 2017 | $381,000 | +7.0% | 3,150 | 0.0% | 0.05% | +8.7% |
| Q1 2017 | $356,000 | +4.1% | 3,150 | 0.0% | 0.05% | +7.0% |
| Q4 2016 | $342,000 | -52.2% | 3,150 | -27.6% | 0.04% | -55.2% |
| Q3 2016 | $716,000 | +15.3% | 4,350 | 0.0% | 0.10% | +21.5% |
| Q2 2016 | $621,000 | +12.5% | 4,350 | +1.2% | 0.08% | +16.2% |
| Q1 2016 | $552,000 | -14.0% | 4,300 | 0.0% | 0.07% | -6.8% |
| Q4 2015 | $642,000 | – | 4,300 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $14,787,000 | 2.73% |
| DeepCurrents Investment Group LLC | 416,800 | $9,620,000 | 0.33% |
| DUALITY ADVISERS, LP | 105,668 | $2,439,000 | 0.21% |
| EULAV Asset Management | 335,000 | $7,732,000 | 0.21% |
| Virtus ETF Advisers LLC | 19,375 | $447,000 | 0.19% |
| Hennion & Walsh Asset Management, Inc. | 135,214 | $3,121,000 | 0.19% |
| PDT Partners, LLC | 110,592 | $2,552,000 | 0.18% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 70,256 | $1,622,000 | 0.16% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $3,896,000 | 0.12% |
| WOODWARD DIVERSIFIED CAPITAL, LLC | 8,939 | $206,000 | 0.12% |